APA (7th ed.) Citation

I, E., D, W., VD, N., A, D., V, W., MA, S., . . . A, M. (2026). Population pharmacokinetic modeling of piperacillin in critically ill adult patients: Consideration of sex-based differences during model development. Expert review of clinical pharmacology, 19(1), 69. https://doi.org/10.1080/17512433.2026.2620530

Chicago Style (17th ed.) Citation

I, El-Haffaf, et al. "Population Pharmacokinetic Modeling of Piperacillin in Critically Ill Adult Patients: Consideration of Sex-based Differences During Model Development." Expert Review of Clinical Pharmacology 19, no. 1 (2026): 69. https://doi.org/10.1080/17512433.2026.2620530.

MLA (9th ed.) Citation

I, El-Haffaf, et al. "Population Pharmacokinetic Modeling of Piperacillin in Critically Ill Adult Patients: Consideration of Sex-based Differences During Model Development." Expert Review of Clinical Pharmacology, vol. 19, no. 1, 2026, p. 69, https://doi.org/10.1080/17512433.2026.2620530.